Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP150817

Influenza A H7 Hemagglutinin Antibody (InA414), Novus Biologicals™
SDP

Catalog No. NBP150817 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP150817 0.25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP150817 Supplier Novus Biologicals Supplier No. NBP150817
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Influenza A H7 Hemagglutinin Monoclonal antibody specifically detects Influenza A H7 Hemagglutinin in Virus samples. It is validated for Western Blot, ELISA.

Specifications

Antigen Influenza A H7 Hemagglutinin
Applications Western Blot, ELISA, Immunoassay
Classification Monoclonal
Clone InA414
Conjugate Unconjugated
Dilution Western Blot 1:100-1:2000, ELISA 1:100-1:2000, Immunoassay
Host Species Mouse
Immunogen Hybridoma clone has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with Influenza A/Netherlands/219/03 (strain H7N7).
Purification Method Protein G purified
Quantity 0.25 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human, Virus
Content And Storage Store at 4C. Do not freeze.
Form Purified
Isotype IgG2b
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.